↓ Skip to main content

Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy

Overview of attention for article published in Journal of NeuroVirology, April 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
96 Mendeley
Title
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy
Published in
Journal of NeuroVirology, April 2013
DOI 10.1007/s13365-013-0162-1
Pubmed ID
Authors

Assawin Gongvatana, Jaroslaw Harezlak, Steven Buchthal, Eric Daar, Giovanni Schifitto, Thomas Campbell, Michael Taylor, Elyse Singer, Jeffrey Algers, Jianhui Zhong, Mark Brown, Deborah McMahon, Yuen T. So, Deming Mi, Robert Heaton, Kevin Robertson, Constantin Yiannoutsos, Ronald A. Cohen, Bradford Navia, HIV Neuroimaging Consortium

Abstract

Emerging evidence suggests that CNS injury and neurocognitive impairment persist in the setting of chronic HIV infection and combination antiretroviral therapy (CART). Yet, whether neurological injury can progress in this setting remains uncertain. Magnetic resonance spectroscopy and neurocognitive and clinical assessments were performed over 2 years in 226 HIV-infected individuals on stable CART, including 138 individuals who were neurocognitively asymptomatic (NA). Concentrations of N-acetylaspartate (NAA), creatine (Cr), choline (Cho), myoinositol, and glutamate/glutamine (Glx) were measured in the midfrontal cortex (MFC), frontal white matter (FWM), and basal ganglia (BG). Longitudinal changes in metabolite levels were determined using linear mixed effect models, as were metabolite changes in relation to global neurocognitive function. HIV-infected subjects showed significant annual decreases in brain metabolite levels in all regions examined, including NAA (2.95 %) and Cho (2.61 %) in the FWM; NAA (1.89 %), Cr (1.84 %), Cho (2.19 %), and Glx (6.05 %) in the MFC; and Glx (2.80 %) in the BG. Similar metabolite decreases were observed in the NA and subclinically impaired subgroups, including subjects with virologic suppression in plasma and CSF. Neurocognitive decline was associated with longitudinal decreases in Glx in the FWM and the BG, and in NAA in the BG. Widespread progressive changes in the brain, including neuronal injury, occur in chronically HIV-infected persons despite stable antiretroviral treatment and virologic suppression and can lead to neurocognitive declines. The basis for these findings is poorly understood and warrants further study.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Netherlands 1 1%
Unknown 94 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 15%
Researcher 13 14%
Student > Doctoral Student 12 13%
Student > Master 11 11%
Professor 9 9%
Other 18 19%
Unknown 19 20%
Readers by discipline Count As %
Medicine and Dentistry 22 23%
Neuroscience 10 10%
Psychology 8 8%
Agricultural and Biological Sciences 7 7%
Nursing and Health Professions 5 5%
Other 20 21%
Unknown 24 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2013.
All research outputs
#13,687,464
of 22,708,120 outputs
Outputs from Journal of NeuroVirology
#448
of 925 outputs
Outputs of similar age
#105,665
of 194,081 outputs
Outputs of similar age from Journal of NeuroVirology
#3
of 4 outputs
Altmetric has tracked 22,708,120 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 925 research outputs from this source. They receive a mean Attention Score of 4.2. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,081 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.